BI
BIHE39.SA iShares US Pharmaceuticals ETF
- BRL
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 1.32%
- Fundamental score
- -
Is BIHE39.SA undervalued?
Graham numberThe Graham number of iShares US Pharmaceuticals ETF cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
iShares US Pharmaceuticals ETF fundamental analysis
No fundamental analysis for iShares US Pharmaceuticals ETF yet.
iShares US Pharmaceuticals ETF stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of iShares US Pharmaceuticals ETF are not available yet.
iShares US Pharmaceuticals ETF dividends
iShares US Pharmaceuticals ETF has not paid dividends in the last 1 fiscal years.
Last stock split: 3:1 on Mar 7, 2024.
Who owns iShares US Pharmaceuticals ETF
Ownership data of iShares US Pharmaceuticals ETF is not available yet.
iShares US Pharmaceuticals ETF company profile
- Company name
- iShares US Pharmaceuticals ETF
- Ticker
- BIHE39.SA
- Exchange
- Sao Paulo Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -